Has Akhil Parashar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $57,680 in general payments to Akhil Parashar, MD across 386 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Akhil Parashar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Akhil Parashar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Akhil Parashar, MD

Clinical Cardiac Electrophysiology · Salisbury, MDNPI 1205246477

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.1%), food and beverage and grants — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 25.8% of the total.

$57,680in general payments, 2019–2025

Across 386 payments — averaging $149.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$15K
Boston Scientific$14K
Biotronik Inc.$14K
Abbott$12K
Biosense Webster, Inc.$763
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$448
plus $749 from 10 others

What the payments were for

Grants$15,75027%
Travel & lodging$25,43944%
Food & beverage$16,05228%
Education$4391%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	136	$14,876
Boston Scientific	48	$14,436
Biotronik Inc.	86	$13,997
Abbott	66	$12,411
Biosense Webster, Inc.	9	$763
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	17	$448
Medical Device Business Services, Inc.	1	$216
Novartis	6	$164
E.r. Squibb & Sons, L.L.C.	5	$96
AstraZeneca	3	$71
Atricure, Inc.	3	$61
Kestra Medical Technology Services, Inc.	2	$46
Altathera Pharmaceuticals LLC	1	$37
Angiodynamics, Inc.	1	$23
Scpharmaceuticals Inc.	1	$19
Lexicon Pharmaceuticals, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL BRADY$5,000
EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$5,000
GENERAL - THERAPIES$2,935
AVEIR$2,463
EnSite Precision Cardiac Mapping System$2,459
Micra$2,059
Ensite Cardiac Mapping System$1,628
Acticor 7 VR-T DX$1,601
DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
Carto 3$769
Rivacor 7 DR-T$756
Sentus$756
Edora 8 DR-T$756
Selectra$521
EVERA MRI XT DR SURESCAN$427
BioMonitor$407
AURORA EV-ICD MRI SURESCAN$291
OCTARAY MAPPING CATHETER$271
HeartMate 3 Left Ventricular Dev$215
ASSURITY$160

How this compares

$57,680 in reported general payments places this provider in the 80th percentile of 63 clinical cardiac electrophysiology providers in Maryland.

See all clinical cardiac electrophysiology providers in Maryland →

Medicare billing

Part B allowed, 2024

$572,175

Medicare patients

1,959

Services billed

9,103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	180	$173,741
XareltoRivaroxaban	54	$61,247
MultaqDronedarone Hcl	19	$13,745
Dabigatran EtexilateDabigatran Etexilate Mesylate	23	$6,053
Flecainide Acetate	82	$3,607
Metoprolol Succinate	131	$2,011
Ranolazine ErRanolazine	16	$2,007
Verapamil ErVerapamil Hcl	118	$1,407
Mexiletine Hcl	19	$1,304
Amiodarone Hcl	106	$1,292
Diltiazem 24hr Er (Cd)Diltiazem Hcl	30	$881
SotalolSotalol Hcl	14	$624
Propafenone Hcl	20	$442
Chlorthalidone	34	$392
Metolazone	11	$349

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Salisbury

Stephen KeimSalisbury$17K
Scott KaufmanSalisbury$11K
Emmanuel NsahSalisbury$10K
Sean BeinartRockville$315K
Charles LoveBaltimore$238K
Hugh CalkinsBaltimore$202K
Paresh ShahBaltimore$97K
Helen BaroldRockville$83K
Jonathan ChrispinBaltimore$77K
Sung LeeTakoma Park$68K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →